S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The 1 Stock To Watch In This Market. (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The 1 Stock To Watch In This Market. (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The 1 Stock To Watch In This Market. (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The 1 Stock To Watch In This Market. (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
Will Advanced Micro Devices Follow NVIDIA Higher? 
NYSE:RBOT

Vicarious Surgical - RBOT Stock Forecast, Price & News

$2.46
+0.20 (+8.85%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.30
$2.47
50-Day Range
$2.24
$3.50
52-Week Range
$1.69
$6.00
Volume
175,429 shs
Average Volume
297,157 shs
Market Capitalization
$309.86 million
P/E Ratio
82.00
Dividend Yield
N/A
Price Target
$6.00

Vicarious Surgical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
143.9% Upside
$6.00 Price Target
Short Interest
Bearish
18.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$880,955 Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.56) to ($0.64) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

219th out of 983 stocks

Surgical Appliances & Supplies Industry

8th out of 23 stocks


RBOT stock logo

About Vicarious Surgical (NYSE:RBOT) Stock

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

RBOT Stock News Headlines

This Trade Strategy Outpaces Almost Anything
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Earnings Preview: Vicarious Surgical
Vicarious Surgical to Participate in Upcoming Conferences
Pittsburgh CREATES in partnership with surgical firm
One Tiny Incision
Earnings Outlook For Vicarious Surgical
Vicarious Surgical Inc.
See More Headlines
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

RBOT Company Calendar

Last Earnings
2/13/2023
Today
3/22/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+143.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$5.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.88 per share

Miscellaneous

Free Float
59,854,000
Market Cap
$309.86 million
Optionable
Optionable
Beta
1.25














RBOT Stock - Frequently Asked Questions

Should I buy or sell Vicarious Surgical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RBOT shares.
View RBOT analyst ratings
or view top-rated stocks.

What is Vicarious Surgical's stock price forecast for 2023?

1 brokers have issued twelve-month price objectives for Vicarious Surgical's stock. Their RBOT share price forecasts range from $5.00 to $7.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 143.9% from the stock's current price.
View analysts price targets for RBOT
or view top-rated stocks among Wall Street analysts.

How have RBOT shares performed in 2023?

Vicarious Surgical's stock was trading at $2.02 at the beginning of 2023. Since then, RBOT shares have increased by 21.8% and is now trading at $2.46.
View the best growth stocks for 2023 here
.

When is Vicarious Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our RBOT earnings forecast
.

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc (NYSE:RBOT) issued its quarterly earnings results on Monday, February, 13th. The company reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02. During the same quarter last year, the business earned ($0.15) earnings per share.

What is Vicarious Surgical's stock symbol?

Vicarious Surgical trades on the New York Stock Exchange (NYSE) under the ticker symbol "RBOT."

Who are Vicarious Surgical's major shareholders?

Vicarious Surgical's stock is owned by many different retail and institutional investors. Top institutional shareholders include MY.Alpha Management HK Advisors Ltd (2.49%), DDD Partners LLC (1.54%), Geode Capital Management LLC (0.68%), Jane Street Group LLC (0.43%), Charles Schwab Investment Management Inc. (0.27%) and Morgan Stanley (0.18%). Insiders that own company stock include Adam David Sachs, June Morris, Philip Liang, Sammy Khalifa and William John Kelly.
View institutional ownership trends
.

How do I buy shares of Vicarious Surgical?

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vicarious Surgical's stock price today?

One share of RBOT stock can currently be purchased for approximately $2.46.

How much money does Vicarious Surgical make?

Vicarious Surgical (NYSE:RBOT) has a market capitalization of $309.86 million. The company earns $5.16 million in net income (profit) each year or $0.03 on an earnings per share basis.

How can I contact Vicarious Surgical?

Vicarious Surgical's mailing address is 78 Fourth Avenue Waltham, MA 02451. The official website for the company is www.vicarioussurgical.com. The company can be reached via phone at 617 868 1700 or via email at ir@vicarioussurgical.com.

This page (NYSE:RBOT) was last updated on 3/22/2023 by MarketBeat.com Staff